• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过植物性饮食预防和逆转高血压引起的冠状动脉微血管功能障碍。

Prevention and reversal of hypertension-induced coronary microvascular dysfunction by a plant-based diet.

作者信息

Najjar Rami S, Hekmatyar Nedumangalam, Wang Yanling, Ngo Vu, Lail Hannah L, Tejada Juan P, Danh Jessica P, Wanders Desiree, Feresin Rafaela G, Mehta Puja K, Gewirtz Andrew T

机构信息

Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.

Advanced Translational Imaging Facility, Georgia State University, Atlanta, GA 30303, USA.

出版信息

bioRxiv. 2025 Aug 6:2025.04.19.649660. doi: 10.1101/2025.04.19.649660.

DOI:10.1101/2025.04.19.649660
PMID:40799580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12340848/
Abstract

BACKGROUND AND AIMS

Coronary microvascular dysfunction (CMD) is associated with adverse cardiovascular outcomes. CMD is driven by endothelial and vascular smooth muscle cell (VSMC) dysfunction. We aimed to test whether CMD could be mitigated by a plant-based diet (PBD) in an animal model of hypertension.

METHODS

We compared 28- and 40-week-old female normotensive Wistar-Kyoto and spontaneously hypertensive (SHR) rats, maintained, from age 4 weeks, on a control refined diet or a PBD, comprised of 28% fruits, vegetables, nuts and legumes. A subset of control SHRs were switched to the PBD at 28 weeks. CMD was assessed by coronary flow reserve via echocardiogram. Cardiac microvascular endothelial function was assessed via cMRI. Endothelial and VSMC function were assessed in the left ventricle (LV) or in isolated VSMCs. The role of gut microbiota was probed via 16S sequencing and antibiotics. Cardiac inflammation, oxidative stress, and fibrosis were also explored.

RESULTS

SHRs exhibited endothelial dysfunction and likely VSMC dysfunction. PBD did not ameliorate their hypertension but, nonetheless, prevented and reversed CMD. PBD's mitigation of CMD was associated with improved endothelial nitric oxide synthase function and NO-mediated VSMC signaling, as well as reductions in LV oxidative stress, inflammatory signaling, and fibrosis. PBD altered the gut microbiota, although antibiotic studies failed to establish its importance in ameliorating CMD.

CONCLUSIONS

A PBD prevented CMD development and reversed established CMD in SHRs. Such benefits of PBD, which occurred without alleviating hypertension, were possibly due to improved endothelial function and likely improved VSMC function. These results support clinical trials to test PBDs in human CMD.

摘要

背景与目的

冠状动脉微血管功能障碍(CMD)与不良心血管结局相关。CMD由内皮细胞和血管平滑肌细胞(VSMC)功能障碍驱动。我们旨在测试在高血压动物模型中,植物性饮食(PBD)是否可减轻CMD。

方法

我们比较了28周龄和40周龄的雌性正常血压Wistar-Kyoto大鼠和自发性高血压(SHR)大鼠,从4周龄开始,分别维持在对照精制饮食或PBD上,PBD由28%的水果、蔬菜、坚果和豆类组成。一部分对照SHR在28周时改为PBD。通过超声心动图评估冠状动脉血流储备来评估CMD。通过心脏磁共振成像(cMRI)评估心脏微血管内皮功能。在左心室(LV)或分离的VSMC中评估内皮细胞和VSMC功能。通过16S测序和抗生素探究肠道微生物群的作用。还探讨了心脏炎症、氧化应激和纤维化。

结果

SHR表现出内皮功能障碍,可能还有VSMC功能障碍。PBD并未改善它们的高血压,但尽管如此,预防并逆转了CMD。PBD对CMD的缓解与内皮型一氧化氮合酶功能改善、NO介导的VSMC信号传导改善以及LV氧化应激、炎症信号传导和纤维化减少有关。PBD改变了肠道微生物群,尽管抗生素研究未能证实其在改善CMD中的重要性。

结论

PBD可预防SHR中CMD的发展并逆转已形成的CMD。PBD的这种益处发生在未减轻高血压的情况下,可能是由于内皮功能改善以及可能的VSMC功能改善。这些结果支持在人类CMD中测试PBD的临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/5a045d7cabc6/nihpp-2025.04.19.649660v2-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/8eebffc0165b/nihpp-2025.04.19.649660v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/6159dddf072f/nihpp-2025.04.19.649660v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/8a800bb8538c/nihpp-2025.04.19.649660v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/bdf9f3cf540b/nihpp-2025.04.19.649660v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/40cff34f5952/nihpp-2025.04.19.649660v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/3b5f8b1b3db1/nihpp-2025.04.19.649660v2-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/3ff288363385/nihpp-2025.04.19.649660v2-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/3319bf1fb181/nihpp-2025.04.19.649660v2-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/5f911358263b/nihpp-2025.04.19.649660v2-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/28cd583673b3/nihpp-2025.04.19.649660v2-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/e7ca77f24de7/nihpp-2025.04.19.649660v2-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/999258e9df9c/nihpp-2025.04.19.649660v2-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/44239bcb7449/nihpp-2025.04.19.649660v2-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/d16f2938ac6c/nihpp-2025.04.19.649660v2-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/5a045d7cabc6/nihpp-2025.04.19.649660v2-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/8eebffc0165b/nihpp-2025.04.19.649660v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/6159dddf072f/nihpp-2025.04.19.649660v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/8a800bb8538c/nihpp-2025.04.19.649660v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/bdf9f3cf540b/nihpp-2025.04.19.649660v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/40cff34f5952/nihpp-2025.04.19.649660v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/3b5f8b1b3db1/nihpp-2025.04.19.649660v2-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/3ff288363385/nihpp-2025.04.19.649660v2-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/3319bf1fb181/nihpp-2025.04.19.649660v2-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/5f911358263b/nihpp-2025.04.19.649660v2-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/28cd583673b3/nihpp-2025.04.19.649660v2-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/e7ca77f24de7/nihpp-2025.04.19.649660v2-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/999258e9df9c/nihpp-2025.04.19.649660v2-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/44239bcb7449/nihpp-2025.04.19.649660v2-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/d16f2938ac6c/nihpp-2025.04.19.649660v2-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/12340848/5a045d7cabc6/nihpp-2025.04.19.649660v2-f0015.jpg

相似文献

1
Prevention and reversal of hypertension-induced coronary microvascular dysfunction by a plant-based diet.通过植物性饮食预防和逆转高血压引起的冠状动脉微血管功能障碍。
bioRxiv. 2025 Aug 6:2025.04.19.649660. doi: 10.1101/2025.04.19.649660.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
4
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
5
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2015 Oct 9(10):CD008649. doi: 10.1002/14651858.CD008649.pub2.
6
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
7
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
8
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.
9
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
10
Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.心肌声学造影评估冠状动脉微血管功能障碍预测射血分数保留的心力衰竭患者的主要不良心血管事件的随访。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):496. doi: 10.1186/s12872-024-04173-7.

本文引用的文献

1
Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice.小鼠心肌缺血再灌注后冠状动脉血流储备的动态评估。
J Vis Exp. 2023 Aug 25(198). doi: 10.3791/65391.
2
Crosstalk between oxidative stress and epigenetic marks: New roles and therapeutic implications in cardiac fibrosis.氧化应激与表观遗传标记的串扰:心脏纤维化中的新作用和治疗意义。
Redox Biol. 2023 Sep;65:102820. doi: 10.1016/j.redox.2023.102820. Epub 2023 Jul 17.
3
Dietary Polyphenol, Gut Microbiota, and Health Benefits.膳食多酚、肠道微生物群与健康益处。
Antioxidants (Basel). 2022 Jun 20;11(6):1212. doi: 10.3390/antiox11061212.
4
MRI-based in vivo detection of coronary microvascular dysfunction before alterations in cardiac function induced by short-term high-fat diet in mice.基于 MRI 的活体检测:在短期高脂肪饮食诱导的心脏功能改变之前,检测小鼠冠状动脉微血管功能障碍。
Sci Rep. 2021 Sep 23;11(1):18915. doi: 10.1038/s41598-021-98401-1.
5
Vegan Diet and the Gut Microbiota Composition in Healthy Adults.纯素饮食与健康成年人的肠道微生物组成。
Nutrients. 2021 Jul 13;13(7):2402. doi: 10.3390/nu13072402.
6
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.微血管性心绞痛患者的临床特征和预后:冠状动脉血管舒缩障碍国际研究(COVADIS)组的一项国际前瞻性队列研究。
Eur Heart J. 2021 Nov 21;42(44):4592-4600. doi: 10.1093/eurheartj/ehab282.
7
Berries and Their Polyphenols as a Potential Therapy for Coronary Microvascular Dysfunction: A Mini-Review.浆果及其多酚作为治疗冠状动脉微血管功能障碍的潜在疗法:小型综述。
Int J Mol Sci. 2021 Mar 25;22(7):3373. doi: 10.3390/ijms22073373.
8
Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial.超重女性微血管性心绞痛的综合治疗 - 一项随机对照的初步试验研究。
PLoS One. 2020 Nov 5;15(11):e0240722. doi: 10.1371/journal.pone.0240722. eCollection 2020.
9
Functional coronary angiography in symptomatic patients with no obstructive coronary artery disease.有症状但无阻塞性冠状动脉疾病患者的功能性冠状动脉造影。
Catheter Cardiovasc Interv. 2021 Nov 1;98(5):827-835. doi: 10.1002/ccd.29237. Epub 2020 Sep 9.
10
Treatment of coronary microvascular dysfunction.冠状动脉微血管功能障碍的治疗。
Cardiovasc Res. 2020 Mar 1;116(4):856-870. doi: 10.1093/cvr/cvaa006.